Table 3.

The predicted genes involved in the cell cycle and proliferation pathways in breast cancer patients.

Up-regulated

AKT2, BCL2,CCND1, EGFR, IGFIR, MYC,PI3KR1, IGFB1, IGFB2, IGFBR2, BCL2, CCND1, FZD9, MAPK1, MAPK9, MYC, SMAD4, TGFBR2, FGFR1, FZD9, FZD4, MAPK1, MAPK9, SMAD4, FZD3, MYC, FGF1, FGF18, PIK3R1, FGF2, WNT16, BRAF, WNT4, WNT2B, WNT9A, AKT3, FGF23, IGF1, WNT10B, IGF1R, WNT3, WNT5A, PIK3CB, CDK6, NCOA3, MAPK1, AKT2, FGF1, WNT4, WNT9A, AKT3, WNT4, PIK3R3, WNT9A, AKT3, RAF1, PIK3CB, FGF2, PIK3R1, FGF1,CDK6, CDK4, FZD10,IGF1R, FZD2, WNT3, WNT9B, FZD3,FGF8, WNT5B, KRAS, FGFR1, EGFR, WNT2, FZD3, FGF23, WNT8B, WNT1, IGF1, MAP3K2, AKT2, MAPK1, WNT7B, RAF1, WNT5A, PIK3CB, PIK3CA, PIK3R1, FGF1, CDK6, WNT16, BRAF, MYC, AKT3, WNT5A, FGFR1, KRAS, WNT10B, FGF9, IGF1R, WNT7B, FGFR1, PIK3R3, FZD3, POLK, EGFR, BRAF, AKT3, RAF1, PIK3CB, MAPK1, FGF5, FGF2, PIK3R1, POLK, CDK6, WNT2, WNT16, BRAF, KRAS, IGF1, FGF7, IGF1R, WNT9B, NCOA3, MAPK1, WNT7B, LRP6, CDK4, IGF1, RPS6KB1, RPS6KB2, PIK3R1, WNT8A, PIK3CD, FGF1, BRAF, NCOA1, WNT5A, TFAP2A, APPL1, JAG1, SHC3, JUN, SHC1, SHC2, CTNNB1, DVL3, DVL1, LEF1, ERBB2, HES5, FLT4, CDKN1A, DLL4, GADD45B, SOCS7, SOCS5, SESN3, BCL2L2, GABRB1, NUFIP2

Down-regulated

APC, PTEN, FOXO3, PDCD4, TP53, TCF7L2, E2F2, TCF7, POLK, BAK1, TP53, BRCA1, APC2, E2F1, GSK3B, BAX, SP1, RB1, GSK3B, HOXD10,SP1, AP1, TCF7, FRAT2, FRAT1, ESR1, ESR2, BAK1, DDB2,E2F3, ESRRG, CYCS, MSH2, MSH6, MSH3, ACVR1B, KIT, HEYL, GADD45A, CSNK1A1, CSNK1A1L, TNFSF11, SCH3, AXIN2, ZDHHC21, PTEN, CCND1, FOXO1, SOCS2